MICHELLE WASDEN: Open Payments
NPI 1700875333 · PLEASANT VIEW, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 17 payments from 12 companies in 2025. Trend: 2023 $287 · 2024 $296 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $49 |
| ABBVIE INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $33 |
| Corium, LLC | 1 | $24 |
| Cranial Technologies, Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $16 |
Products named: Veozah, VRAYLAR, TRELEGY ELLIPTA, NURTEC ODT, Azstarys, Doc Band, FARXIGA, Auvelity.
Industry payments across UT — which companies pay providers there.
